NASDAQ · Drug Manufacturers - Specialty & Generic
InMed Pharmaceuticals Inc (INM)
$1.29
-1.53%
37
In band
Moving averages
SMA 200$1.18+9.32%
Company profile
InMed Pharmaceuticals Inc., a clinical-stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company is headquartered in Vancouver, Canada.
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Market cap$7.09M
P/E ratioNone
EPS$-2.84
Beta0.978
Dividend yield0.00%
52-week high$2.50
52-week low$0.58
Similar stocks in Drug Manufacturers - Specialty & Generic
HIMS
Hims & Hers Health Inc - Class A
RSI 43
CGC
Canopy Growth Corporation
RSI 36
BFRI
Biofrontera Inc
RSI 60
TLRY
Tilray Brands Inc - Class 2
RSI 33
LNTH
Lantheus Holdings Inc
RSI 43
ACB
Aurora Cannabis Inc
RSI 53
BCRX
Biocryst Pharmaceuticals Inc
RSI 30
ORGO
Organogenesis Holdings Inc - Class A
RSI 29
ZTS
Zoetis Inc - Class A
RSI 57
AQST
Aquestive Therapeutics Inc
RSI 52
RSI alerts for INM
Get an email the moment InMed Pharmaceuticals Inc crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 13 September 2026 at 1:35 PM EDT